Use of cholinesterase antagonists to treat insulin resistance

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 45/06 (2006.01) A61K 9/00 (2006.01) A61K 9/127 (2006.01) A61K 31/14 (2006.01) A61K 31/165 (2006.01) A61K 31/216 (2006.01) A61K 31/27 (2006.01) A61K 31/407 (2006.01) A61K 31/4425 (2006.01) A61K 31/473 (2006.01) A61K 31/55 (2006.01) A61K 31/6615 (2006.01) A61K 31/662 (2006.01) A61K 38/38 (2006.01) A61L 31/16 (2006.01) A61P 3/10 (2006.01) A61P 5/50 (2006.01)

Patent

CA 2514088

There is provided a method of reducing insulin resistance in a mammalian subject comprising administering a suitable acetylcholine esterase antagonist.

La présente invention concerne un procédé permettant la réduction de la résistance à l'insuline chez un mammifère comportant l'administration d'un antagoniste approprié de l'acétylcholine estérase.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of cholinesterase antagonists to treat insulin resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of cholinesterase antagonists to treat insulin resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cholinesterase antagonists to treat insulin resistance will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1366588

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.